MYOSTEATOSIS AND MUSCLE LOSS IMPACT LIVER TRANSPLANT OUTCOMES IN MALE PATIENTS WITH HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Lu, Di [2 ]
Hu, Zhihang [1 ]
Xu, Xiao [2 ]
机构：
[1] Hangzhou Med Coll, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1422
引用
收藏
页码：S1080 / S1080
页数：1
相关论文
共 50 条
  • [41] Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
    Halazun, Karim J.
    Rosenblatt, Russell E.
    Mehta, Neil
    Lai, Quirino
    Hajifathalian, Kaveh
    Gorgen, Andre
    Brar, Gagan
    Sasaki, Kazunari
    Doyle, Maria B. Majella
    Tabrizian, Parissa
    Agopian, Vatche G.
    Najjar, Marc
    Ivanics, Tommy
    Samstein, Benjamin
    Brown, Robert S., Jr.
    Emond, Jean C.
    Yao, Francis
    Lerut, Jan
    Rossi, Massimo
    Mennini, Gianluca
    Iesari, Samuele
    Finkenstedt, Armin
    Schaefer, Benedikt
    Mittler, Jans
    Hoppe-Lotichius, Maria
    Quintini, Cristiano
    Aucejo, Federico
    Chapman, William
    Sapisochin, Gonzalo
    JAMA SURGERY, 2021, 156 (06) : 559 - 567
  • [42] Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma
    Tabrizian, Parissa
    Holzner, Matthew L.
    Mehta, Neil
    Halazun, Karim
    Agopian, Vatche G.
    Yao, Francis
    Busuttil, Ronald W.
    Roberts, John
    Emond, Jean C.
    Samstein, Benjamin
    Brown, Robert S., Jr.
    Najjar, Marc
    Chapman, William C.
    Doyle, Majella Mb
    Florman, Sander S.
    Schwartz, Myron E.
    Llovet, Josep M.
    JAMA SURGERY, 2022, 157 (09) : 779 - 788
  • [43] Implications of Dynamic α-Fetoprotein on Outcomes Following Liver Transplant for Hepatocellular Carcinoma
    Ling, Xi Liang
    Han, Eun Young
    Chen, Zheyuan
    JAMA SURGERY, 2022, 157 (04) : 359 - 360
  • [44] Patient-reported outcomes in liver transplant recipients with hepatocellular carcinoma
    Kensinger, Clark D.
    Feurer, Irene D.
    O'Dell, Heather W.
    LaNeve, David C.
    Simmons, Lindsey
    Pinson, C. Wright
    Moore, Derek E.
    CLINICAL TRANSPLANTATION, 2016, 30 (09) : 1036 - 1045
  • [45] Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant
    Montano-Loza, Aldo J.
    Mazurak, Vera C.
    Ebadi, Maryam
    Meza-Junco, Judith
    Sawyer, Michael B.
    Baracos, Vickie E.
    Kneteman, Norman
    HEPATOLOGY, 2018, 67 (03) : 914 - 923
  • [46] Impact and outcomes of liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
    Cortese, Sergio
    Tellado, Jose M.
    CIRUGIA Y CIRUJANOS, 2022, 90 (05): : 579 - 587
  • [47] Impact of Local Therapy on Outcomes in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation
    Lin, T. A.
    Paul, N.
    Cheung, D.
    Saberi, B.
    Ottman, S.
    Gurakar, A.
    Yarchoan, M.
    Narang, A.
    Kim, A. K.
    Meyer, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E316 - E316
  • [48] Impact of Preexisting Diabetes Mellitus on Outcomes of Liver Transplantation in Patients With Hepatocellular Carcinoma.
    Al Hasan, Ibrahim
    Chan, Albert C. Y.
    Chok, Kenneth S. H.
    Chan, See Ching
    Lo, Chung Mau
    LIVER TRANSPLANTATION, 2014, 20 : S336 - S336
  • [49] Intraoperative blood loss is an independent promoter of tumor recurrence in liver transplant patients with advanced hepatocellular carcinoma
    Kornberg, Arno
    Witt, Ulrike
    Kornberg, Jennifer
    Friess, Hemut
    Thrum, Katharina
    TRANSPLANTATION, 2016, 100 (07) : S212 - S212
  • [50] Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
    Carrie E. Ryan
    Jacob Lambdin
    Shimul Shah
    Ralph Cutler Quillin
    Kristina Lemon
    Jonathan M. Hernandez
    Davendra Sohal
    Annals of Surgical Oncology, 2023, 30 : 686 - 687
12345